These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22064597)

  • 21. Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction
    Vicen M; Vitverova B; Havelek R; Blazickova K; Machacek M; Rathouska J; Najmanová I; Dolezelova E; Prasnicka A; Sternak M; Bernabeu C; Nachtigal P
    FASEB J; 2019 May; 33(5):6099-6114. PubMed ID: 30753095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsia.
    Gu Y; Groome LJ; Alexander JS; Wang Y
    Placenta; 2012 Oct; 33(10):803-9. PubMed ID: 22840244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras.
    Ichimiya H; Maeda K; Enomoto A; Weng L; Takahashi M; Murohara T
    Biochem Biophys Res Commun; 2015 May; 461(2):260-7. PubMed ID: 25869066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.
    Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D
    J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
    Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
    FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice.
    Li J; Zhao Y; Choi J; Ting KK; Coleman P; Chen J; Cogger VC; Wan L; Shi Z; Moller T; Zheng X; Vadas MA; Gamble JR
    PLoS Biol; 2020 Jun; 18(6):e3000734. PubMed ID: 32502201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction.
    Habib A; Karmali V; Polavarapu R; Akahori H; Cheng Q; Pachura K; Kolodgie FD; Finn AV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2425-31. PubMed ID: 23887639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide.
    Yakovlev S; Cao C; Galisteo R; Zhang L; Strickland DK; Medved L
    Thromb Haemost; 2019 Nov; 119(11):1816-1826. PubMed ID: 31466086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex.
    Broman MT; Kouklis P; Gao X; Ramchandran R; Neamu RF; Minshall RD; Malik AB
    Circ Res; 2006 Jan; 98(1):73-80. PubMed ID: 16322481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.
    Helbing T; Wiltgen G; Hornstein A; Brauers EZ; Arnold L; Bauer A; Esser JS; Diehl P; Grundmann S; Fink K; Patterson C; Bode C; Moser M
    Inflammation; 2017 Apr; 40(2):442-453. PubMed ID: 27995357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling.
    Benn A; Bredow C; Casanova I; Vukičević S; Knaus P
    J Cell Sci; 2016 Jan; 129(1):206-18. PubMed ID: 26598555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise training inhibits atherosclerosis progression and reduces VE-cadherin levels within atherosclerotic plaques in hypercholesterolemic mice.
    Kadoglou NPE; Stasinopoulou M; Christodoulou E; Valsami G; Kostomitsopoulos N
    Biochem Biophys Res Commun; 2022 Oct; 623():39-43. PubMed ID: 35870260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
    Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of oxidized low-density lipoprotein (ox-LDL) on radiation-induced endothelial-to-mesenchymal transition.
    Kim M; Choi SH; Jin YB; Lee HJ; Ji YH; Kim J; Lee YS; Lee YJ
    Int J Radiat Biol; 2013 May; 89(5):356-63. PubMed ID: 23289363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.
    Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J
    PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage.
    Sidibé A; Mannic T; Arboleas M; Subileau M; Gulino-Debrac D; Bouillet L; Jan M; Vandhuick T; Le Loët X; Vittecoq O; Vilgrain I
    Arthritis Rheum; 2012 Jan; 64(1):77-87. PubMed ID: 21905018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Puerarin Protects Against LPS-Induced Vascular Endothelial Cell Hyperpermeability via Preventing Downregulation of Endothelial Cadherin.
    Deng HF; Wang S; Wang XL; Li L; Xie F; Zeng ZW; Zhang WX
    Inflammation; 2019 Aug; 42(4):1504-1510. PubMed ID: 31102123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.
    Chen J; Wang J; Su C; Qian W; Sun L; Sun H; Chen J; Zhang H; Zhang J
    Inflamm Res; 2016 Mar; 65(3):213-24. PubMed ID: 26681130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.